Borrelia WB IgG: A Key Biomarker in Lyme Disease Diagnostics
The Borrelia Western Blot IgG (Immunoglobulin G) is a vital component in the diagnostic process for Lyme disease, an infection caused by the bacterium Borrelia burgdorferi. IgG antibodies are part of the body’s adaptive immune response and typically develop weeks to months after initial infection, indicating either past exposure or a current, longer-term immune response. Because Lyme disease is a complex, multi-stage illness with varying symptomatology depending on the stage, the IgG Western Blot test provides valuable insights, especially in patients with symptoms that suggest chronic or late-stage infection.
Understanding Borrelia WB IgG in the Context of Lyme Disease
In the typical two-step testing approach recommended by the CDC, an enzyme-linked immunosorbent assay (ELISA) is conducted first to screen for Lyme disease. If this test is positive or equivocal, a Western Blot test is used to confirm the diagnosis, distinguishing between the presence of IgG and IgM antibodies to Borrelia burgdorferi. For an IgG Western Blot to be considered positive, it generally requires reactivity to at least 5 out of 10 specified protein bands. These bands represent different proteins of Borrelia burgdorferi, with each band corresponding to a different molecular weight protein such as P41 (flagellin), OspC, and P100. The presence of these antibodies suggests that the immune system has previously encountered the bacterium and has generated a memory response, which is characteristic of a later or persistent infection.
IgG antibodies play a critical role in long-term immunity and are often present in the bloodstream long after the initial infection. As a result, a positive IgG test does not necessarily mean that the infection is active but does indicate past exposure to the Lyme-causing bacteria. Therefore, a positive Borrelia WB IgG result, when combined with clinical symptoms, provides strong evidence that a patient may be dealing with Lyme disease. However, clinicians consider this result alongside the IgM test and clinical history to differentiate between an active infection and residual antibodies from a past infection.
The Role of P100 in the IgG Panel
The P100 antigen, a 100 kDa protein specific to Borrelia burgdorferi, is often included in the Western Blot IgG panel and can be particularly indicative of later-stage Lyme disease or a prolonged immune response. P100 is one of several proteins the immune system may recognize and produce antibodies against over time, though it tends to become detectable after the infection has persisted for an extended period. Its presence, alongside other IgG bands, supports the likelihood of a more established infection. Because P100 reactivity usually correlates with the later stages of Lyme disease, it’s often absent in early infection, making it a specific marker in cases where Lyme disease has progressed.
While P100 is informative, it does not stand alone as a diagnostic criterion. A positive P100 result should be assessed with other reactive bands in the IgG Western Blot, helping confirm the immune system’s response to various Borrelia antigens over time. Clinically, this may also point to cases where a patient has been infected but was either undiagnosed or untreated in the early stages, allowing the infection to advance. As such, P100's presence on the IgG panel supports the likelihood of a persistent or chronic infection rather than a recent, acute exposure.
Borrelia WB IgM and Its Relationship with IgG and P100
The Borrelia Western Blot IgM test detects Immunoglobulin M (IgM) antibodies, which generally develop early after infection and are considered markers of acute or recent infection. In cases of new Lyme disease infection, IgM antibodies tend to appear within 2 to 4 weeks and may persist for several months. A positive IgM result typically requires reactivity to 2 of 3 bands, focusing on different proteins than the IgG panel. The IgM Western Blot helps identify an active immune response early in infection, which is particularly useful for diagnosing Lyme disease in patients with recent exposure or early-stage symptoms.
When both IgM and IgG antibodies are positive, it may indicate an ongoing or progressive infection where the immune response is evolving. Over time, as the immune system's response matures, IgM antibodies often decline, while IgG antibodies, such as those targeting P100, become more prominent. Therefore, in chronic or late-stage Lyme disease, IgM antibodies may no longer be present, while IgG antibodies, including those directed at P100, reflect an established immune response.
The relationship between IgM and IgG is important diagnostically because it indicates different stages of infection. A positive IgM with a negative IgG generally points to early Lyme disease, while a positive IgG without IgM could indicate a past infection or a later stage of Lyme. If both IgM and IgG are positive, it may reflect an ongoing infection or the body's continued immune response. In cases where P100 is also positive on the IgG panel, it can signal that the infection is long-standing or that there has been prolonged immune activation, which can be especially relevant for patients presenting with persistent or chronic symptoms. This combination of results can help clinicians decide whether treatment is necessary and guide the approach to patient management.
Clinical Interpretation of Borrelia WB IgG, IgM, and P100 Results
Interpreting these test results can be complex. If a patient has a positive IgM but a negative IgG, it often signifies a recent infection, and treatment may be pursued to prevent the disease from progressing. However, a positive IgG without IgM generally suggests past exposure, possibly without an active infection. In cases where P100 is positive, it may indicate that the immune system had prolonged exposure to Borrelia burgdorferi, potentially pointing toward a late-stage or persistent infection. This is particularly relevant for patients with ongoing symptoms that resemble late-stage Lyme disease or post-treatment Lyme disease syndrome (PTLDS).
The combination of a positive IgG, including reactivity to P100, with a negative IgM can sometimes be observed in patients who have had Lyme disease in the past and now have lasting antibodies. However, clinicians consider these findings alongside symptom history, exposure risk, and additional diagnostic tools to determine whether the infection is active or if lingering antibodies are responsible for the immune response. Persistent antibodies, especially in chronic or late Lyme disease, can result in ongoing immune reactivity even after treatment, which may contribute to symptoms.
Conclusion
The Borrelia WB IgG test, particularly in conjunction with IgM and markers like P100, is a crucial tool in the diagnosis and management of Lyme disease. The presence of IgG antibodies suggests past exposure or a longer-term immune response, with P100 adding significant diagnostic value by indicating the possibility of chronic infection. Meanwhile, the IgM test is invaluable for identifying early-stage Lyme, offering insight into recent exposure. Together, these biomarkers provide a comprehensive picture of the infection stage, allowing clinicians to tailor treatment approaches. However, given the complexities of Lyme disease, these results are best interpreted with clinical evaluation, ensuring that a patient’s history, symptomatology, and test results align for an accurate diagnosis.
All Your Lab Results.
One Simple Dashboard.
Import, Track, and Share Your Lab Results Easily
Import, Track, and Share Your Lab Results
Import lab results from multiple providers, track changes over time, customize your reference ranges, and get clear explanations for each result. Everything is stored securely, exportable in one organized file, and shareable with your doctor—or anyone you choose.
Cancel or upgrade anytime
Laboratories
Bring All Your Lab Results Together — In One Place
We accept reports from any lab, so you can easily collect and organize all your health information in one secure spot.
Pricing Table
Gather Your Lab History — and Finally Make Sense of It
Finally, Your Lab Results Organized and Clear
Personal plans
$79/ year
Advanced Plan
Access your lab reports, explanations, and tracking tools.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 5 reports entered for you
- Cancel or upgrade anytime
$250/ once
Unlimited Account
Pay once, access everything—no monthly fees, no limits.
- Import lab results from any provider
- Track all results with visual tools
- Customize your reference ranges
- Export your full lab history anytime
- Share results securely with anyone
- Receive 10 reports entered for you
- No subscriptions. No extra fees.
$45/ month
Pro Monthly
Designed for professionals managing their clients' lab reports
- Import lab results from any provider
- Track lab results for multiple clients
- Customize reference ranges per client
- Export lab histories and reports
- Begin with first report entered by us
- Cancel or upgrade anytime
About membership
What's included in a Healthmatters membership
Import Lab Results from Any Source
See Your Health Timeline
Understand What Your Results Mean
Visualize Your Results
Data Entry Service for Your Reports
Securely Share With Anyone You Trust
Let Your Lab Results Tell the Full Story
Once your results are in one place, see the bigger picture — track trends over time, compare data side by side, export your full history, and share securely with anyone you trust.
Bring all your results together to compare, track progress, export your history, and share securely.
What Healthmatters Members Are Saying
Frequently asked questions
Healthmatters is a personal health dashboard that helps you organize and understand your lab results. It collects and displays your medical test data from any lab in one secure, easy-to-use platform.
- Individuals who want to track and understand their health over time.
- Health professionals, such as doctors, nutritionists, and wellness coaches, need to manage and interpret lab data for their clients.
With a Healthmatters account, you can:
- Upload lab reports from any lab
- View your data in interactive graphs, tables, and timelines
- Track trends and monitor changes over time
- Customize your reference ranges
- Export and share your full lab history
- Access your results anytime, from any device
Professionals can also analyze client data more efficiently and save time managing lab reports.
Healthmatters.io personal account provides in-depth research on 10000+ biomarkers, including information and suggestions for test panels such as, but not limited to:
- The GI Effects® Comprehensive Stool Profile,
- GI-MAP,
- The NutrEval FMV®,
- The ION Profile,
- Amino Acids Profile,
- Dried Urine Test for Comprehensive Hormones (DUTCH),
- Organic Acids Test,
- Organix Comprehensive Profile,
- Toxic Metals,
- Complete Blood Count (CBC),
- Metabolic panel,
- Thyroid panel,
- Lipid Panel,
- Urinalysis,
- And many, many more.
You can combine all test reports inside your Healthmatters account and keep them in one place. It gives you an excellent overview of all your health data. Once you retest, you can add new results and compare them.
If you are still determining whether Healthmatters support your lab results, the rule is that if you can test it, you can upload it to Healthmatters.
We implement proven measures to keep your data safe.
At HealthMatters, we're committed to maintaining the security and confidentiality of your personal information. We've put industry-leading security standards in place to help protect against the loss, misuse, or alteration of the information under our control. We use procedural, physical, and electronic security methods designed to prevent unauthorized people from getting access to this information. Our internal code of conduct adds additional privacy protection. All data is backed up multiple times a day and encrypted using SSL certificates. See our Privacy Policy for more details.